Impaired Fetal Environment and Gestational Age: What Is Driving Mortality in Neonates With Critical Congenital Heart Disease?

被引:29
|
作者
Steurer, Martina A. [1 ,2 ]
Peyvandi, Shabnam [1 ,2 ]
Baer, Rebecca J. [3 ,4 ]
Oltman, Scott P. [2 ]
Chambers, Christina D. [4 ]
Norton, Mary E. [3 ]
Ryckman, Kelli K. [5 ]
Moon-Grady, Anita J. [1 ]
Keller, Roberta L. [1 ]
Shiboski, Stephen C. [2 ]
Jelliffe-Pawlowski, Laura L. [2 ]
机构
[1] Univ Calif San Francisco, Dept Pediat, 550 16th St,5th Floor, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Dept Pediat, La Jolla, CA USA
[5] Univ Iowa, Coll Publ Hlth, Dept Epidemiol, Iowa City, IA USA
来源
关键词
congenital heart disease; fetal environment; maternal placental syndrome; small for gestational age; MATERNAL PLACENTAL SYNDROMES; CARDIOVASCULAR HEALTH; GROWTH RESTRICTION; BIRTH-WEIGHT; PREECLAMPSIA; ASSOCIATION; SURGERY; DEFECTS; IMPACT; RISK;
D O I
10.1161/JAHA.119.013194
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Infants with critical congenital heart disease (CCHD) are more likely to be small for gestational age (SGA) or born to mothers with maternal placental syndrome. The objective of this study was to investigate the relationship between maternal placental syndrome, SGA, and gestational age (GA) on 1-year mortality in infants with CCHD. Methods and Results-In a population-based administrative database of all live-born infants in California (2007-2012) we identified all infants with CCHD without chromosomal anomalies. Our primary predictor was an impaired fetal environment (IFE), defined as presence of maternal placental syndrome or SGA. We calculated hazard ratios to quantify the association between different components of IFE and 1-year mortality and conducted a causal mediation analysis to assess GA at birth as a mediator. We identified 6863 infants with CCHD. IFE was present in 25.1%. Infants with IFE were more likely to die than infants without IFE (16.6% versus 11.1%; hazard ratios 1.55, 95% CI 1.34-1.78). Only SGA (hazard ratios 1.76, 95% CI 1.50-2.05) and placental abruption (hazard ratios 1.70, 95% CI 1.17-2.48) were significantly associated with mortality; preeclampsia and gestational hypertension had no significant association with mortality. The mediation analysis showed that 32.8% (95% CI 24.9-47.0%) of the relationship between IFE and mortality is mediated through GA. Conclusions-IFE is a significant contributor to outcomes in the CCHD population. SGA and placental abruption are the main drivers of postnatal mortality while other maternal placental syndrome components had much less of an impact. Only one third of the effect between IFE and mortality is mediated through GA.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Blood Pressure Screening for Critical Congenital Heart Disease in Neonates
    Kristi L. Boelke
    John S. Hokanson
    Pediatric Cardiology, 2014, 35 : 1349 - 1355
  • [22] Perinatal Stressors and Consequences for Neonates with Critical Congenital Heart Disease
    Ronai, Christina
    Katlaps, Isabel
    Kim, Amanda
    Valent, Amy M.
    Thornburg, Kent L.
    Madriago, Erin
    JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2023, 10 (12)
  • [23] Critical congenital heart disease screening with a pulse oximetry in neonates
    Hamilcikan, Sahin
    Can, Emrah
    JOURNAL OF PERINATAL MEDICINE, 2018, 46 (02) : 203 - 207
  • [24] Timing of Delivery and Outcomes in Neonates With Critical Congenital Heart Disease
    Costello, John M.
    Polito, Angelo
    Brown, David W.
    McElrath, Thomas F.
    Graham, Dionne A.
    Thiagarajan, Ravi R.
    Bacha, Emile A.
    Allan, Catherine K.
    Cohen, Jennifer N.
    Laussen, Peter C.
    CIRCULATION, 2009, 120 (18) : S585 - S585
  • [25] Intrapartum Fetal Heart Rate Tracing Among Small-for-Gestational Age Compared With Appropriate-for-Gestational-Age Neonates
    Chauhan, Suneet P.
    Weiner, Steven J.
    Saade, George R.
    Belfort, Michael A.
    Reddy, Uma M.
    Thorp, John M., Jr.
    Tita, Alan T. N.
    Miller, Russell S.
    Dinsmoor, Mara J.
    McKenna, David S.
    Stetzer, Bradley
    Rouse, Dwight J.
    Gibbs, Ronald S.
    El-Sayed, Yasser Y.
    Sorokin, Yoram
    Caritis, Steve N.
    OBSTETRICS AND GYNECOLOGY, 2018, 132 (04): : 1019 - 1025
  • [26] Indicators for perinatal mortality in neonates diagnosed with congenital heart disease.
    Patel, R
    Brumund, MR
    Leggio, LE
    Lutin, WA
    JOURNAL OF INVESTIGATIVE MEDICINE, 2000, 48 (01) : 109A - 109A
  • [27] Pulse Oximetry Screening for Detecting Critical Congenital Heart Disease in Neonates
    Jain, Deepshikha
    Jain, Manish
    Lamture, Yashwant
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (12)
  • [28] DEVELOPMENT OF REGIONAL CEREBRAL HEMODYNAMICS IN NEONATES WITH CRITICAL CONGENITAL HEART DISEASE
    Ko, T.
    Lynch, J. M.
    Newland, J. J.
    Winters, M.
    Busch, D. R.
    McCarthy, A. L.
    Nicolson, S. C.
    Montenegro, L. M.
    Fuller, S.
    Gaynor, J. W.
    Spray, T. L.
    Naim, M. Y.
    Yodh, A. G.
    Licht, D. J.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2016, 36 : 235 - 235
  • [29] Pulse Oximetry Overestimates Oxyhemoglobin in Neonates with Critical Congenital Heart Disease
    Murphy, Daniel
    Pak, Youngju
    Cleary, John Patrick
    NEONATOLOGY, 2016, 109 (03) : 213 - 218
  • [30] Transfer of Neonates with Critical Congenital Heart Disease Within a Regionalized Network
    Swartz, Michael F.
    Cholette, Jill M.
    Orie, Jennifer M.
    Jacobs, Marshall L.
    Jacobs, Jeffrey P.
    Alfieris, George M.
    PEDIATRIC CARDIOLOGY, 2017, 38 (07) : 1350 - 1358